Biogen reports strong enrollment progress in the AMETHYST clinical trial testing litifilimab in cutaneous lupus erythematosus (CLE).

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SAN DIEGO — A novel combination of elsubrutinib and ...

An investigational Toll-like receptor (TLR) antagonist was effective in reducing biomarkers and clinical symptoms of systemic lupus erythematosus (SLE) in a pilot trial, evidence that the innate ...

Lupus nephritis frequently recurs in the transplanted kidney, sometimes without clinical signs. Lupus nephritis frequently recurs after kidney transplantation, and it may be clinically quiescent, ...

Please provide your email address to receive an email when new articles are posted on . Overall, 56% of participants had a lupus nephritis class change on repeat biopsy. Of patients with initial ...

Acute kidney injury (AKI) in patients with lupus nephritis is tied with rapid disease worsening and potential progression to chronic kidney disease and kidney failure.

Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell subsets with likely roles in disease pathogenesis, according to a study led by ...

CHICAGO -- People who died with systemic lupus erythematosus (SLE) were far more likely than car crash victims to have severe cardiac abnormalities such as heart enlargement, valvulopathy, and ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen McMahon, ...

In a new study, researchers have discovered a connection between inflammation in the areas of interstitial fibrosis and tubular atrophy (IFTA), a common pattern of kidney damage often seen in kidney ...